Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|
40000 | - |
1 * 40000, SDS-PAGE | Homo sapiens |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
N-palmitoyl-D-glucosylsphingosine + H2O | Homo sapiens | - |
palmitic acid + D-glucosylsphingosine | - |
? | |
N-palmitoyl-sphingosylphosphorylcholine + H2O | Homo sapiens | - |
palmitic acid + sphingosylphosphorylcholine | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
epidermis | - |
Homo sapiens | - |
stratum corneum | activity is enhanced more than 5fold in involved stratum corneum, more than 3fold in uninvolved stratum corneum, and approximately 3fold in the involved epidermis from patients with atopic dermatitis compared with healthy controls | Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
N-palmitoyl-D-glucosylsphingosine + H2O | - |
Homo sapiens | palmitic acid + D-glucosylsphingosine | - |
? | |
N-palmitoyl-sphingosylphosphorylcholine + H2O | - |
Homo sapiens | palmitic acid + sphingosylphosphorylcholine | - |
? |
Subunits | Comment | Organism |
---|---|---|
monomer | 1 * 40000, SDS-PAGE | Homo sapiens |
Synonyms | Comment | Organism |
---|---|---|
SM glucosylceramide GCer deacylase | - |
Homo sapiens |
SM-GCer deacylase | - |
Homo sapiens |
SMGCer deacylase | - |
Homo sapiens |
sphingomyelin glucosylceramide deacylase | - |
Homo sapiens |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
5 | - |
- |
Homo sapiens |
Organism | Comment | pI Value Maximum | pI Value |
---|---|---|---|
Homo sapiens | sphingomyelin deacylase activity, isoelectric focusing | - |
4.2 |
General Information | Comment | Organism |
---|---|---|
physiological function | the abnormal expression of sphingomyelin deacylase, which acts as a by-pass enzyme and competes with EC 3.1.4.12 (sphingomyelin phosphodiesterase) as well as EC 3.2.1.45 (glucosylceramidase) for N-acyl-sphingosylphosphorylcholine and D-glucosyl-N-acylsphingosine, respectively, is mainly responsible for the ceramide deficiency in patients with atopic dermatitis. The biogenesis of EC 3.1.4.12 (sphingomyelin phosphodiesterase) as well as EC 3.2.1.45 (glucosylceramidase) may be critical to the pathogenesis of atopic dermatitis | Homo sapiens |